Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Recent Pharmacogenomics Papers of Note: Sep 18, 2013

Premium

PDLIM5 gene polymorphisms and short term antidepressant response in Chinese major depressive disorders.
Liu Z, Zhu F, Yao L, et al.
Int J Clin Exp Med. 2013 Sep 1;6(8):677-82.


PTEN Germline Mutations in Patients Initially Tested for Other Hereditary Cancer Syndromes: Would Use of Risk Assessment Tools Reduce Genetic Testing?
Mester JL, Moore RA, Eng C.
Oncologist. 2013 Sep 13. [Epub ahead of print]


Pharmacotherapy Effects on Smoking Cessation Vary with Nicotine Metabolism Gene (CYP2A6).
Chen LS, Bloom AJ, Baker TB, et al.
Addiction. 2013 Sep 11. [Epub ahead of print]


CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment.
Almoguera B, Riveiro-Alvarez R, Lopez-Castroman J, et al.
Pharmacogenet Genomics. 2013 Sep 9. [Epub ahead of print]


Ethical, legal, and social implications of incorporating genomic information into electronic health records.
Hazin R, Brothers KB, Malin BA, et al.
Genet Med. 2013 Sep 12. [Epub ahead of print]


Warfarin pharmacogenetics: A controlled dose-response study in healthy subjects.
Kadian-Dodov DL, Zee SA, Scott SA, et al.
Vasc Med. 2013 Sep 12. [Epub ahead of print]


Personalizing therapy for colorectal cancer.
Wong A, Ma BB.
Clin Gastroenterol Hepatol. 2013 Sep 8. [Epub ahead of print]


Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.
De Mattia E, Toffoli G, Polesel J, et al.
Pharmacogenet Genomics. 2013 Oct;23(10):549-57.


Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.
Hernandez W, Gamazon ER, Aquino-Michaels K, et al.
Pharmacogenomics J. 2013 Sep 10. [Epub ahead of print]


Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups.
Sorich MJ, Coory M, Pekarsky BA.
PLoS One. 2013 Aug 27;8(8):e72256.

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
Ng C, Sarris J, Singh A, et al.
Hum Psychopharmacol. 2013 Sep;28(5):516-22.


The Diverse Distribution of Risk Factors between Breast Cancer Subtypes of ER, PR and HER2: A 10-Year Retrospective Multi-Center Study in China.
Song Q, Huang R, Li J, et al.
PLoS One. 2013 Aug 20;8(8):e72175.


Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.
Cooper AJ, Narasimhan S, Rickels K, Lohoff FW.
Psychiatry Res. 2013 Aug 22. [Epub ahead of print]


The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.